It’s interesting that the new method devised by UNSW is not yet recognized by the regulatory body and that NOX has to go backwards to move forwards. At least pre-clinical work is comparatively cheap.
It would be great if NOX are able to release efficacy data in any one of the three clinical trials on the back of this announcement. With the media push on this announcement there could be alot of new faces to drive a much needed re-rate before the next cap raise.
- Forums
- ASX - By Stock
- NOX
- News: NOX Noxopharm Announces Results From Novel Dual-Cell Therapy Pancreatic Cancer Study
News: NOX Noxopharm Announces Results From Novel Dual-Cell Therapy Pancreatic Cancer Study, page-5
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.6¢ |
Change
-0.002(2.94%) |
Mkt cap ! $19.28M |
Open | High | Low | Value | Volume |
6.7¢ | 6.9¢ | 6.6¢ | $13.31K | 198.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1137 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.7¢ | 22400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1137 | 0.066 |
1 | 100000 | 0.064 |
3 | 47786 | 0.061 |
4 | 105033 | 0.060 |
2 | 120000 | 0.059 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 12000 | 2 |
0.080 | 12099 | 2 |
0.081 | 22345 | 2 |
0.083 | 40000 | 1 |
0.090 | 25689 | 3 |
Last trade - 15.50pm 28/06/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online